These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20505677)

  • 1. Losartan inhibits LPS-induced inflammatory signaling through a PPARgamma-dependent mechanism in human THP-1 macrophages.
    An J; Nakajima T; Kuba K; Kimura A
    Hypertens Res; 2010 Aug; 33(8):831-5. PubMed ID: 20505677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes.
    He M; He X; Xie Q; Chen F; He S
    Thromb Res; 2006; 117(5):579-90. PubMed ID: 15953627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes.
    Iwashita M; Sakoda H; Kushiyama A; Fujishiro M; Ohno H; Nakatsu Y; Fukushima T; Kumamoto S; Tsuchiya Y; Kikuchi T; Kurihara H; Akazawa H; Komuro I; Kamata H; Nishimura F; Asano T
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E286-96. PubMed ID: 22045314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
    Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
    Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation.
    Miyoshi M; Miyano K; Moriyama N; Taniguchi M; Watanabe T
    Eur J Neurosci; 2008 Jan; 27(2):343-51. PubMed ID: 18190523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of gene expression profiles in macrophages stimulated by angiotensin II--angiotensin II induces MCP-2 through AT1-receptor.
    Tone A; Shikata K; Ogawa D; Sasaki S; Nagase R; Sasaki M; Yozai K; Usui HK; Okada S; Wada J; Shikata Y; Makino H
    J Renin Angiotensin Aldosterone Syst; 2007 Mar; 8(1):45-50. PubMed ID: 17487826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy.
    Xiao J; Leung JC; Chan LY; Tang SC; Lai KN
    Clin Immunol; 2009 Aug; 132(2):266-76. PubMed ID: 19443277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation.
    Wu GJ; Chen TL; Ueng YF; Chen RM
    Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulators.
    Apostolakis S; Krambovitis E; Vlata Z; Kochiadakis GE; Baritaki S; Spandidos DA
    Thromb Res; 2007; 121(3):387-95. PubMed ID: 17521710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat.
    Liu L; Qiu HB; Yang Y; Wang L; Ding HM; Li HP
    Arch Biochem Biophys; 2009 Jan; 481(1):131-6. PubMed ID: 18940180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renin-angiotensin system mediates hyperoxia-induced collagen production in human lung fibroblasts.
    Lang YD; Hung CL; Wu TY; Wang LF; Chen CM
    Free Radic Biol Med; 2010 Jul; 49(1):88-95. PubMed ID: 20353822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive effect of angiotensin receptor blocker on stimulation of mice CTLs by angiotensin II.
    Maeda A; Okazaki T; Inoue M; Kitazono T; Yamasaki M; Lemonnier FA; Ozaki S
    Int Immunopharmacol; 2009 Sep; 9(10):1183-8. PubMed ID: 19540938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zedoarondiol isolated from the rhizoma of Curcuma heyneana is involved in the inhibition of iNOS, COX-2 and pro-inflammatory cytokines via the downregulation of NF-kappaB pathway in LPS-stimulated murine macrophages.
    Cho W; Nam JW; Kang HJ; Windono T; Seo EK; Lee KT
    Int Immunopharmacol; 2009 Aug; 9(9):1049-57. PubMed ID: 19398040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2.
    Martin L; Pingle SC; Hallam DM; Rybak LP; Ramkumar V
    J Pharmacol Exp Ther; 2006 Jan; 316(1):71-8. PubMed ID: 16188954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma.
    Ge H; Zhang JF; Guo BS; He Q; Wang BY; He B; Wang CQ
    Vascul Pharmacol; 2007 Feb; 46(2):114-21. PubMed ID: 17055343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling.
    Ii M; Matsunaga N; Hazeki K; Nakamura K; Takashima K; Seya T; Hazeki O; Kitazaki T; Iizawa Y
    Mol Pharmacol; 2006 Apr; 69(4):1288-95. PubMed ID: 16373689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages.
    Kim HY; Kim JR; Kim HS
    J Microbiol Biotechnol; 2008 Jun; 18(6):1170-8. PubMed ID: 18600064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.